Ventricular-arterial coupling: definition, pathophysiology and therapeutic targets in cardiovascular disease

Sahrai Saeed1, Hannes Holm2,3, Peter M Nilsson3

  • 1Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.

Insights

Ventricular-arterial coupling (VAC) assesses cardiovascular efficiency. Newer methods like the pulse wave velocity (PWV) to global longitudinal strain (GLS) ratio may better predict outcomes than traditional echocardiography.

Area of Science:

  • Cardiovascular physiology
  • Arteriosclerosis research
  • Hemodynamics

Background:

  • Arteriosclerosis affects the heart and arteries, impacting ventricular-arterial coupling (VAC), a measure of cardiovascular efficiency.
  • Traditional VAC assessment uses echocardiography (Ea/Ees), but evolving methods include PWV/GLS ratio and myocardial work index.
  • Cardio-metabolic risk factors detrimentally affect the aorta and left ventricle (LV), influencing arterial load and LV function.

Purpose of the Study:

  • To review the hemodynamic basis of VAC.
  • To discuss the clinical implications and therapeutic interventions for normalizing VAC.
  • To update on arterial load's impact on LV function.

Main Methods:

  • This is a narrative review based on a systematic search of PubMed.
  • The review covers the hemodynamic background, clinical implications, and therapeutic interventions for VAC.
  • It also summarizes the effects of risk factors on the aorta and LV.

Main Results:

  • Newer methods, such as the PWV/GLS ratio, may offer superior prediction of target organ damage compared to traditional echocardiographic measures.
  • Therapeutic interventions, including novel anti-diabetic drugs and optimized antihypertensive treatments, show potential in normalizing VAC.
  • Understanding VAC is crucial for managing cardiovascular health in high-risk patients.

Conclusions:

  • The PWV/GLS ratio may be a more effective marker for predicting outcomes than traditional echocardiographic VAC assessment.
  • Optimized medical treatments can normalize VAC in high-risk individuals.
  • VAC is a key indicator of global cardiovascular health and response to therapy.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
122
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
119
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
948
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
233
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.1K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
78